The significantly differentially expressed genes include common clinical biomarkers for macrophages (CD68 and CD163) and DCIS cells (EPCAM, KRT7, KRT18, and ERBB2 [also known as HER2]) (Fig. 4C; Supplemental File 3). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.